Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, 1007, Shimo-Nagakubo, Sunto- Nagaizumi, Shizuoka, 4118777, Japan.
Division of Diagnostic Pathology, Shizuoka Cancer Center, Shizuoka, Japan.
World J Surg. 2021 Feb;45(2):581-589. doi: 10.1007/s00268-020-05834-2. Epub 2020 Oct 20.
Surgical resection in patients with extrahepatic cholangiocarcinoma (EHCC) with paraaortic lymph node metastasis (PALNM) remains controversial. The objective of this study was to investigate the prognostic impact of PALNM in resected EHCC.
The present retrospective study included 410 patients, including 16 patients with PALNM, who underwent surgical resection of EHCC between September 2002 and December 2018. These were compared to 9 patients in whom EHCC was not resected due to PALNM. The clinicopathological features and survival outcomes were investigated to identify the prognostic factors in resected EHCC.
The overall survival in the resected patients with PALNM was significantly better than that in unresected patients (median survival time [MST] 33.7 vs. 16.7 months, p=0.009) and was not significantly worse than that of patients with regional lymph node metastasis (LNM) (MST 33.7 vs 36.0 months, p=0.278). The multivariate analysis identified age > 70 years, male sex, tumor location (perihilar), residual tumor status, histological grade, microscopic venous invasion, and regional LNM as independent prognostic factors.
There was no significant difference in survival between the resected patients with PALNM and patients with regional LNM, and PALNM was not a significant prognostic factor in the multivariate analysis. Surgical resection may be considered an acceptable approach for EHCC with PALNM in selected patients.
伴有腹主动脉旁淋巴结转移(PALNM)的肝外胆管癌(EHCC)患者的手术切除仍存在争议。本研究旨在探讨切除的 EHCC 中 PALNM 的预后影响。
本回顾性研究纳入了 410 例患者,其中 16 例为 PALNM 患者,他们于 2002 年 9 月至 2018 年 12 月接受了 EHCC 的手术切除。与 9 例因 PALNM 未接受 EHCC 切除的患者进行比较。调查临床病理特征和生存结果,以确定切除的 EHCC 的预后因素。
PALNM 切除患者的总体生存率明显优于未切除患者(中位生存时间 [MST] 33.7 与 16.7 个月,p=0.009),与区域淋巴结转移(LNM)患者的 MST(33.7 与 36.0 个月,p=0.278)无显著差异。多因素分析确定年龄>70 岁、男性、肿瘤位置(肝门周围)、残余肿瘤状态、组织学分级、镜下静脉侵犯和区域 LNM 为独立的预后因素。
PALNM 切除患者与区域 LNM 患者的生存无显著差异,PALNM 在多因素分析中不是显著的预后因素。在选定的患者中,手术切除可能被认为是一种可接受的治疗伴有 PALNM 的 EHCC 的方法。